Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as potential therapeutic agents in multiple sclerosis.

Olaf Stüve1, Thomas Prod'homme, Sawsan Youssef

  • 1Department of Neurology, University of California-San Francisco, 521 Parnassus Avenue, C-440, San Francisco, CA 94143-0114, USA.

Current Neurology and Neuroscience Reports
|April 23, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.

Multiple sclerosis (Houndmills, Basingstoke, England)·2020
Same author

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.

EBioMedicine·2020
Same author

[Ocrelizumab for treatment of multiple sclerosis].

Der Nervenarzt·2020
Same author

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS.

Neurology(R) neuroimmunology & neuroinflammation·2020
Same author

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.

EBioMedicine·2020
Same author

COVID-19 and management of neuroimmunological disorders.

Nature reviews. Neurology·2020

Statins, or HMG CoA reductase inhibitors, are cholesterol-lowering drugs with anti-inflammatory and neuroprotective effects. Further clinical trials are needed to determine their benefit for neurodegenerative diseases like multiple sclerosis.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Statins (HMG CoA reductase inhibitors) are oral medications widely used for lowering cholesterol.
  • They are known for their good tolerability and safety profile.
  • Statins function by inhibiting HMG CoA reductase, a key enzyme in cholesterol synthesis.

Purpose of the Study:

  • To explore the pleiotropic effects of statins beyond cholesterol reduction.
  • To investigate the potential anti-inflammatory and neuroprotective properties of statins.
  • To assess the potential clinical utility of statins in neurodegenerative diseases.

Main Methods:

  • Review of existing literature on statin mechanisms and reported effects.
  • Analysis of the biochemical pathway involving HMG CoA reductase and L-mevalonate.

Related Experiment Videos

  • Discussion of pleiotropic effects, including anti-inflammatory and neuroprotective actions.

    • Main Results:

    • Statins competitively inhibit HMG CoA reductase, impacting cholesterol synthesis.
    • L-mevalonate, a key intermediate, has metabolites involved in protein modification, influencing cell processes.
    • Emerging evidence suggests statins possess anti-inflammatory and neuroprotective capabilities.

    Conclusions:

    • Statins exhibit significant biological effects independent of their cholesterol-lowering action.
    • Potential therapeutic applications in neuroinflammation and neuroprotection are indicated.
    • Prospective randomized clinical trials are essential to validate statin efficacy in conditions such as multiple sclerosis and other central nervous system neurodegenerative diseases.